Related Experiment Video
Updated: Mar 24, 2026
10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
10.6K
miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia
A Navarro1, S Pairet2,3, A Álvarez-Larrán3,4
1Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain.
Blood Cancer Journal
|March 19, 2016
Summary
Platelets from essential thrombocythemia (ET) patients lacking known mutations show a distinct microRNA (miRNA) signature. This signature involves specific miRNAs that may regulate the JAK/STAT pathway, offering insights into ET
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Essential thrombocythemia (ET) is a myeloproliferative neoplasm with an unknown biological basis in patients lacking known mutations.
- MicroRNAs (miRNAs) are crucial regulators of hematopoietic differentiation and are implicated in various hematologic malignancies.
- miRNA expression patterns in ET, particularly in JAK2V617F-negative cases, remain underexplored.
Purpose of the Study:
- To investigate the miRNA expression profile in platelets of essential thrombocythemia patients, especially those without common mutations.
- To identify specific miRNA signatures associated with ET and explore their potential role in disease pathogenesis.
- To elucidate the relationship between miRNA dysregulation and the JAK/STAT signaling pathway in ET.
Main Methods:
- miRNA profiling was conducted on platelets from 19 ET patients and 10 healthy controls.
- Hierarchical cluster analysis was used to identify distinct miRNA signatures.
- Bioinformatic analysis was employed to identify miRNA targets and associated pathways, with validation of specific miRNA-target interactions.
Main Results:
- A characteristic 70-miRNA signature was identified in ET platelets, with 68 miRNAs downregulated compared to controls (P<0.0001).
- Distinct miRNA signatures were found in JAK2V617F-positive (40 miRNAs) and JAK2V617F-negative ET patients.
- Specific miRNAs (miR-15a, miR-150, miR-519a) were differentially expressed based on mutational status. SOCS1 and SOCS3 were validated as targets of miR-221 and miR-203, respectively, with inverse correlations observed.
Conclusions:
- Platelets from JAK2V617F-negative ET patients exhibit a unique miRNA signature.
- This miRNA signature may contribute to the modulation of the JAK/STAT pathway through the regulation of key genes like SOCS1 and SOCS3.
- The findings provide novel insights into the molecular mechanisms underlying ET in patients with unknown mutations.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
01:21Hematopoiesis
9.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.7K
01:15Differentiation of Common Myeloid Progenitor Cells
4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
01:19Multipotency of Hematopoietic Stem Cells
4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
01:16TGF - β Signaling Pathway
10.9K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K